Citigroup Maintains Buy on GoodRx Holdings, Raises Price Target to $5
Citigroup analyst Daniel Grosslight maintains GoodRx Holdings (NASDAQ: GDRX ) with a Buy and raises the price target from $4 to $5.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.